Gastrointestinal stromal tumours (GISTs) are rares connective tumors, usually located in the stomach or small intestine. Derived from Cajal cells or one of their precursors.
Gastrointestinal stromal tumors (GISTs) represent 1% to 2% of all neoplasms of the digestive tract, The average age is between 50 and 60 years old, most often occurring in the stomach, Their clinical symptomatology is variable according to the region affected or the size of the lesion, they are responsibles for digestive bleeding, pain, or abdominal mass, as well as an alteration in the general state of health. More rarely, the diagnosis is made on the occasion of an intestinal occlusion. the GIST complicated by occlusion due either to invagination of the tumour mass or to exophytic development of the tumour. In CT scans, they are manifested by a localised parietal tumour thickening of variable size with most often an exophytic development. Molecular biology plays an important role in this disease.
The main treatment is radical surgery .The Imatinib has radically changed the prognosis of patients with unresectable and/or metastatic GIST.
We report the case of a patient with a stromal tumour complicated by occlusion operated in emergency in the department of visceral surgical emergencies of Ibn Rochd UHC.